88 results on '"Lai E"'
Search Results
2. Fibronectin type III domain-containing protein 5 (FNDC5)-like immunoreactivity and mRNA abundance in domestic animal tissues
3. Multidisciplinary clinical guidelines in proactive monitoring, early diagnosis, and effective management of trastuzumab deruxtecan (T-DXd)-induced interstitial lung disease (ILD) in breast cancer patients
4. Identification of lenvatinib prognostic index via recursive partitioning analysis in advanced hepatocellular carcinoma
5. Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial
6. The CO2CRC Otway Shallow CO2 Controlled Release Experiment: Site Suitability Assessment
7. Influence of mass transfer and electrolyte composition on anodic oxygen evolution in molten oxides
8. Metacognitive beliefs relate specifically to sleep quality in primary insomnia: a pilot study
9. 118P Immunosenescence and response to immunotherapy in elderly patients: A possible prognostic tool
10. 534P Second-line treatment in older patients with metastatic colorectal cancer: The ELECTRA study
11. 533P First-line treatment in older patients with metastatic colorectal cancer: A large real-world study
12. 66 POSTOPERATIVE COMPLICATIONS AND PELVIC ORGAN PROLAPSE RECURRENCE FOLLOWING COMBINED PELVIC ORGAN PROLAPSE AND RECTAL PROLAPSE SURGERY COMPARED TO PELVIC ORGAN PROLAPSE ONLY SURGERY
13. A42 - Medical management of malignant bowel obstruction: our center experience
14. Immunonutrition supplementation for resectable gastric cancer during standard neoadjuvant chemotherapy of FLOT. A proof-of-concept protocol: I-SUPPLY
15. 126P From tumor height (TH) to tumor regression grade (TRG) in locally advanced rectal cancers (LARC) during total neadjuvant therapy (TNT): A retrospective analysis
16. 109P Early onset metastatic colorectal cancer: Clinical-prognostic characteristics and correlation to molecular status
17. 349P The influence of diabetes on taxane-induced neurotoxicity and quality of life in breast cancer patients
18. P-298 Adjuvant chemotherapy in resected lung-limited metastatic patients with colorectal cancer
19. P-292 The Meta-Lung score: Preoperative clinical score in lung-limited metastatic patients with colorectal cancer
20. P-167 Type 2 diabetes as a predictive and prognostic factor in advanced pancreatic cancer: Preliminary results of the Italian, observational PANCAKE study
21. P-166 Influence of levothyroxine concomitant treatment on treatment responses and outcomes in patients with metastatic colorectal adenocarcinoma
22. P-160 Mismatch repair system protein deficiency as a resistance factor for locally advanced rectal adenocarcinoma patients receiving neoadjuvant chemo-radiotherapy
23. Friction generated ultrasound from geotechnical materials
24. 1469P Efficacy and safety of pembrolizumab/axitinib combination in metastatic renal cell carcinoma (mRCC): A multicentric prospective analysis (ProPAXI study)
25. 373P The role of concomitant RAS and BRAF mutations in influencing clinical outcome during BRAF-targeted treatment for metastatic colorectal cancer
26. A new approach to process control for a bottling plant
27. Postoperative complications and pelvic organ prolapse recurrence following combined rectal prolapse and pelvic organ prolapse surgery compared to pelvic organ prolapse surgery only
28. Fuzzy flow estimation for ultrasound-based liquid level measurement
29. A fuzzy approach to the condition monitoring of a packaging plant
30. Development of a novel ultrasound monitoring system for container filling operations
31. 490P New horizons in metastatic colorectal cancer: Role of CD44 expression
32. 467P Monocyte to red blood cells ratio (MRR): an innovative haematologic prognostic parameter in FOLFIRI-aflibercept treated patients: A subgroup analysis from the DISTINCTIVE trial
33. 459P Dynamic changes of pro-angiogenic factors during FOLFIRI-aflibercept treatment: Interim analysis of DISTINCTIVE trial
34. 417P Liquid biopsy driven anti-EGFR rechallenge in metastatic colorectal cancer
35. P-127 Lymphocyte to monocyte ratio as a prognostic factor in stage IV pancreatic ductal adenocarcinoma naive patients before gemcitabine-nab-paclitaxel chemotherapy
36. P-129 Concomitant RAS and BRAF mutations: Impact on overall survival and progression free survival in metastatic colorectal cancer patients
37. P-128 Influence of anti-diabetic medications on the outcomes of patients with pancreatic ductal adenocarcinoma and type 2 diabetes mellitus
38. 31 Pessary incarceration complicated by vesicovaginal fistula requiring ureteroneocystostomy: A video case presentation
39. 2P Role of neutrophil-to-lymphocyte ratio (NLR) in the outcome of NSCLC EGFR mutated
40. On the mechanism of horizontal gene transfer by Agrobacterium tumefaciens
41. A knowledge based database system for engineering correlations
42. 447P Long term survival with regorafenib: REALITY (real life in Italy) trial - A GISCAD Study
43. 65P Prognostic role of PECS2 index in advanced biliary tract cancer (BTC) patients treated with first line chemotherapy: Training and validation cohorts
44. 668 Kawasaki Disease in the Australian Population: The John Hunter Hospital Experience
45. 601P - Correlation between p53 expression and clinical outcome in RAS/BRAF wild type metastatic colorectal cancer patients receiving later-line irinotecan-cetuximab
46. P-332 - A new prognostic score for biliary tract cancer: a multicenter experience
47. P-296 - Overall survival and progression-free survival in metastatic colorectal cancer patients with concomitant RAS and BRAF mutations: a single center experience
48. P-230 - Effectiveness of CA 19.9 in predicting prognosis in metastatic pancreatic cancer patients treated with nab-paclitaxel plus gemcitabine
49. EP-1324 A Dosimetric Study of Heart and Lung Dose in Breast Radiotherapy-Our Institutional Experience
50. P-209 - P 53 abnormal expression might influence global outcome through EGFR modulation in RAS/BRAF wild type metastatic colorectal cancer patients receiving later-line irinotecan cetuximab
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.